CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention
用于预防自杀的 CAMS 关系代理系统 (CAMS-RAS)
基本信息
- 批准号:9978152
- 负责人:
- 金额:$ 19.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-18 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAdministratorAdultAdvocateAgeAmericanBehavioralBostonCaringCause of DeathClinicalConsultCoping SkillsDevelopmentDistressDoctor of PhilosophyElectronic Health RecordEmergency Department patientEmergency department visitEnsureEvidence based practiceFeedbackFeeling suicidalFutureHealth PersonnelHealthcareHealthcare SystemsHospitalizationHumanInterventionInterviewMarketingMedicalNursesOccupationsParticipantPatientsPhasePhysiciansPoliciesPositioning AttributePrivatizationProceduresProcessProtocols documentationProviderRandomizedRandomized Controlled TrialsReadinessReportingResearchRisk AssessmentSelf EfficacySuicideSuicide attemptSuicide preventionSurgeonSystemTestingTimeTrainingUnited StatesUniversitiesWorkbasebrief interventionclinical decision supportcommercializationcopingcost effectivedesigneconomic costeffective interventionevidence baseexperiencehealth care service organizationhospital readmissionimprovedinnovative technologiespeerpreventpublic health relevancerecruitreducing suicidesuccesssuicidalsuicidal behaviorsuicidal morbiditysuicidal patientsuicidal risksuicide ratesupport toolstoolusabilityvirtual
项目摘要
PROJECT ABSTRACT
Over 44,000 people die annually by suicide in the United States (US) making suicide the 10th leading
cause of death overall and the second leading cause of death among those 10-44. In addition, 9.8 million
adults contemplate suicide annually, and one million will make a suicide attempt. From 2006 to 2013, the rate
of ED visits for suicidal ideation among adults increased by 12% on average annually. While millions are
devoted annually to prevent suicide, suicide rates are rising in the US. Our ultimate aim is to reduce deaths by
suicide while also reducing unnecessary hospitalization, emergency department (ED) and hospital
readmissions, and stop the revolving-door of acute crisis care through the use of innovative technologies.
In Phase I, we proposed to: (1) develop and scientifically validate an avatar for use by suicidal ED patients
that delivers the Collaborative Assessment and Management of Suicidality (CAMS), an efficacious and
cost-effective intervention developed by David Jobes, PhD; and (2) to design clinical support tools and Just-in-
Time training for use by ED medical providers to enhance their delivery of an evidence-based suicide protocol
and facilitate an evidence-based approach to discharge disposition. Our work was also guided by Phase I
reviewers’ concerns. We fully met and exceeded project aims. Most notably, we created a 15-minute avatar
(“Dr. Dave”) who performed a portion of the CAMS Suicide Status Interview which was well-liked and
described as helpful by suicidal ED patients who interacted with “Dr. Dave.”
In Phase II, we propose to complete the development of Virtual CAMS patient and provider tools and to
ready it for EHR integration into EPIC. We will again use an agile process of development and seek feedback
from target end-users. A diverse group of advisors will consult to us to ensure product excellence and
readiness for commercialization. To ensure thorough testing of the product’s provider and patient tools, we will
use a two-condition, randomized study to evaluate Virtual CAMS’ efficacy in preventing suicidal behaviors and
inappropriate/unnecessary hospital admissions, and improving self-efficacy for coping with acute distress.
项目摘要
在美国,每年有超过44,000人死于自杀,使自杀成为第十大自杀原因。
死亡的原因和10-44中的第二大死亡原因。此外,980万
成年人每年都有自杀的念头,有100万人企图自杀。从2006年到2013年,
成年人中因自杀意念就诊的艾德平均每年增加12%。虽然数百万人
每年致力于防止自杀,自杀率在美国上升。我们的最终目标是减少死亡人数,
自杀,同时也减少了不必要的住院、急诊(艾德)和住院
重新入院,并通过使用创新技术停止急性危机护理的旋转门。
在第一阶段,我们提出:(1)开发并科学验证一个虚拟形象,供自杀艾德患者使用
提供自杀的合作评估和管理(CAMS),一个有效的,
大卫乔布斯博士开发的成本效益干预;(2)设计临床支持工具和
艾德医疗服务提供者使用时间培训,以加强其基于证据的自杀协议的交付
并促进以证据为基础的出院处置方法。我们的工作也以第一阶段为指导,
评论家的担忧我们完全达到并超越了项目目标。最值得注意的是,我们创造了一个15分钟的化身,
(“戴夫博士”)谁执行了CAMS自杀状态访谈的一部分,这是很受欢迎的,
被自杀的艾德患者描述为与“戴夫医生”互动的帮助。
在第二阶段,我们建议完成虚拟CAMS患者和提供者工具的开发,
为EHR集成到EPIC做好准备。我们将再次使用敏捷开发过程并寻求反馈
目标最终用户。一个多元化的顾问团队将向我们咨询,以确保产品的卓越性,
为商业化做准备。为了确保对产品的提供者和患者工具进行彻底测试,我们将
使用两种条件的随机研究来评估Virtual CAMS在预防自杀行为方面的有效性,
不适当/不必要的住院,并提高自我效能,以应对急性痛苦。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda A Dimeff其他文献
Linda A Dimeff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda A Dimeff', 18)}}的其他基金
iKinnect Mobile Technology to Reduce Teen Substance Misuse and Health Disparities
iKinnect 移动技术可减少青少年药物滥用和健康差异
- 批准号:
10545162 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health TABA Supplement
使用 Jaspr Health TABA 补充剂治疗初级保健中的自杀驱动者
- 批准号:
10805635 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health
使用 Jaspr Health 在初级保健中治疗自杀驱动者
- 批准号:
10383171 - 财政年份:2021
- 资助金额:
$ 19.18万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health
使用 Jaspr Health 在初级保健中治疗自杀驱动者
- 批准号:
10689325 - 财政年份:2021
- 资助金额:
$ 19.18万 - 项目类别:
iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide Diversity Supplement
iKinnect2.0 涉及青少年司法 自杀风险青少年多样性补充
- 批准号:
10815920 - 财政年份:2021
- 资助金额:
$ 19.18万 - 项目类别:
iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide
iKinnect2.0 青少年司法涉及有自杀风险的青少年
- 批准号:
10625446 - 财政年份:2021
- 资助金额:
$ 19.18万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health
使用 Jaspr Health 在初级保健中治疗自杀驱动者
- 批准号:
10659264 - 财政年份:2021
- 资助金额:
$ 19.18万 - 项目类别:
iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide
iKinnect2.0 青少年司法涉及有自杀风险的青少年
- 批准号:
10255880 - 财政年份:2021
- 资助金额:
$ 19.18万 - 项目类别:
Using Mobile Technology to Enhance MST Outcomes
使用移动技术增强 MST 成果
- 批准号:
8313372 - 财政年份:2013
- 资助金额:
$ 19.18万 - 项目类别:
PracticeGround: Transforming Training and Delivery of Mental Health EBPs
PracticeGround:转变心理健康 EBP 的培训和实施
- 批准号:
8834653 - 财政年份:2011
- 资助金额:
$ 19.18万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Standard Grant